 Andrew Getahun
Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 24 | 2024 | 763 | 3.000 |
Why?
| | Receptors, Antigen, B-Cell | 7 | 2024 | 107 | 1.870 |
Why?
| | Antibody Formation | 9 | 2018 | 266 | 1.710 |
Why?
| | Clonal Anergy | 8 | 2022 | 53 | 1.710 |
Why?
| | B-Lymphocyte Subsets | 5 | 2019 | 68 | 1.610 |
Why?
| | Autoimmune Diseases | 4 | 2022 | 381 | 1.320 |
Why?
| | PTEN Phosphohydrolase | 5 | 2019 | 140 | 1.040 |
Why?
| | Lymphocyte Activation | 9 | 2022 | 1036 | 1.000 |
Why?
| | Signal Transduction | 13 | 2022 | 4501 | 0.990 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2024 | 328 | 0.950 |
Why?
| | T-Lymphocytes | 5 | 2024 | 1735 | 0.900 |
Why?
| | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 5 | 2019 | 13 | 0.890 |
Why?
| | Immunoglobulins | 4 | 2023 | 143 | 0.830 |
Why?
| | Immunoglobulin G | 8 | 2015 | 766 | 0.720 |
Why?
| | Bites and Stings | 1 | 2020 | 30 | 0.670 |
Why?
| | Adjuvants, Immunologic | 3 | 2005 | 206 | 0.660 |
Why?
| | Immune Tolerance | 5 | 2022 | 321 | 0.660 |
Why?
| | Mice | 33 | 2024 | 14847 | 0.650 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2019 | 220 | 0.570 |
Why?
| | Mice, Transgenic | 13 | 2020 | 1947 | 0.570 |
Why?
| | Animals | 41 | 2024 | 31570 | 0.570 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2016 | 7 | 0.560 |
Why?
| | Spleen | 7 | 2020 | 485 | 0.530 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2020 | 129 | 0.520 |
Why?
| | Antigens | 2 | 2009 | 317 | 0.520 |
Why?
| | Autoimmunity | 8 | 2022 | 815 | 0.510 |
Why?
| | Amino Acid Motifs | 2 | 2015 | 197 | 0.510 |
Why?
| | Receptors, Fc | 1 | 2015 | 45 | 0.490 |
Why?
| | Phosphoric Monoester Hydrolases | 4 | 2020 | 54 | 0.490 |
Why?
| | Immunoglobulin E | 4 | 2015 | 314 | 0.480 |
Why?
| | Genotype | 1 | 2020 | 1757 | 0.480 |
Why?
| | Membrane Proteins | 2 | 2018 | 1016 | 0.480 |
Why?
| | Virus Diseases | 1 | 2017 | 195 | 0.470 |
Why?
| | Receptors, IgG | 4 | 2015 | 67 | 0.440 |
Why?
| | Macrophages | 1 | 2020 | 1259 | 0.420 |
Why?
| | Gammaherpesvirinae | 1 | 2012 | 38 | 0.400 |
Why?
| | Down-Regulation | 2 | 2024 | 594 | 0.380 |
Why?
| | Autoantigens | 2 | 2015 | 396 | 0.370 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 138 | 0.370 |
Why?
| | Antibodies, Neutralizing | 1 | 2012 | 222 | 0.350 |
Why?
| | Nitrohydroxyiodophenylacetate | 1 | 2009 | 1 | 0.330 |
Why?
| | Nucleotides, Cyclic | 2 | 2020 | 15 | 0.330 |
Why?
| | Antibodies, Viral | 1 | 2012 | 520 | 0.320 |
Why?
| | Mice, Inbred C57BL | 12 | 2022 | 4682 | 0.310 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2023 | 687 | 0.310 |
Why?
| | Mice, Knockout | 13 | 2019 | 2563 | 0.300 |
Why?
| | Autoantibodies | 5 | 2024 | 1350 | 0.290 |
Why?
| | Epitopes | 1 | 2009 | 434 | 0.280 |
Why?
| | Immunoglobulin M | 4 | 2015 | 245 | 0.280 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2005 | 170 | 0.280 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 3 | 2019 | 97 | 0.280 |
Why?
| | Antibodies | 3 | 2015 | 365 | 0.270 |
Why?
| | Interleukin-4 | 3 | 2019 | 204 | 0.270 |
Why?
| | Antigens, CD | 3 | 2020 | 440 | 0.270 |
Why?
| | Antigen Presentation | 2 | 2005 | 188 | 0.270 |
Why?
| | Immunoglobulin mu-Chains | 2 | 2011 | 7 | 0.260 |
Why?
| | Receptors, IgE | 1 | 2005 | 40 | 0.250 |
Why?
| | T-Lymphocyte Subsets | 2 | 2019 | 383 | 0.250 |
Why?
| | CD4-Positive T-Lymphocytes | 6 | 2021 | 960 | 0.230 |
Why?
| | Immunotherapy | 2 | 2019 | 473 | 0.230 |
Why?
| | CD79 Antigens | 2 | 2014 | 16 | 0.210 |
Why?
| | Ligands | 3 | 2023 | 556 | 0.210 |
Why?
| | Mice, Inbred BALB C | 5 | 2011 | 1144 | 0.200 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 350 | 0.200 |
Why?
| | Adoptive Transfer | 6 | 2015 | 194 | 0.200 |
Why?
| | Immunologic Memory | 2 | 2021 | 313 | 0.200 |
Why?
| | Gene Knock-In Techniques | 2 | 2020 | 46 | 0.190 |
Why?
| | Interleukin-27 | 1 | 2021 | 11 | 0.190 |
Why?
| | Vaccines, Subunit | 1 | 2021 | 41 | 0.190 |
Why?
| | Up-Regulation | 1 | 2004 | 802 | 0.180 |
Why?
| | Costimulatory and Inhibitory T-Cell Receptors | 1 | 2020 | 7 | 0.180 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2021 | 127 | 0.180 |
Why?
| | src-Family Kinases | 3 | 2016 | 88 | 0.170 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 380 | 0.170 |
Why?
| | Receptors, Complement 3d | 2 | 2012 | 130 | 0.170 |
Why?
| | src Homology Domains | 2 | 2020 | 33 | 0.170 |
Why?
| | Disease Models, Animal | 4 | 2022 | 3499 | 0.170 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 76 | 0.160 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2019 | 26 | 0.160 |
Why?
| | Fishes | 1 | 1999 | 80 | 0.160 |
Why?
| | Gene Rearrangement, B-Lymphocyte | 1 | 2018 | 7 | 0.160 |
Why?
| | HLA-DP beta-Chains | 1 | 2019 | 76 | 0.160 |
Why?
| | Mice, 129 Strain | 3 | 2014 | 77 | 0.150 |
Why?
| | Alarmins | 1 | 2018 | 24 | 0.150 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2018 | 34 | 0.150 |
Why?
| | Sheep | 2 | 2012 | 761 | 0.150 |
Why?
| | Antibodies, Monoclonal | 4 | 2022 | 1257 | 0.150 |
Why?
| | Erythrocytes | 4 | 2012 | 568 | 0.150 |
Why?
| | Antigens, Bacterial | 1 | 2018 | 111 | 0.150 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2018 | 11 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2018 | 116 | 0.150 |
Why?
| | Recombination, Genetic | 1 | 2018 | 176 | 0.150 |
Why?
| | Alleles | 1 | 2020 | 789 | 0.140 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 610 | 0.140 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 78 | 0.140 |
Why?
| | Lung Injury | 1 | 2019 | 192 | 0.140 |
Why?
| | Lymphocyte Count | 3 | 2021 | 132 | 0.130 |
Why?
| | Immunoglobulin Class Switching | 1 | 2015 | 15 | 0.130 |
Why?
| | MicroRNAs | 2 | 2019 | 600 | 0.130 |
Why?
| | Humans | 16 | 2023 | 114080 | 0.130 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2022 | 3254 | 0.120 |
Why?
| | Immunomodulation | 1 | 2015 | 84 | 0.120 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2015 | 147 | 0.120 |
Why?
| | Cytokines | 2 | 2019 | 1824 | 0.120 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2015 | 122 | 0.120 |
Why?
| | Germinal Center | 3 | 2015 | 48 | 0.120 |
Why?
| | Protein Binding | 2 | 2020 | 1888 | 0.120 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2014 | 18 | 0.120 |
Why?
| | Mice, Inbred NOD | 3 | 2022 | 552 | 0.110 |
Why?
| | Plasma Cells | 1 | 2014 | 56 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 3 | 2023 | 310 | 0.110 |
Why?
| | Antigens, Ly | 1 | 2013 | 45 | 0.100 |
Why?
| | Listeriosis | 1 | 2013 | 61 | 0.100 |
Why?
| | Mast Cells | 1 | 2013 | 117 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 445 | 0.100 |
Why?
| | Receptors, Immunologic | 1 | 2013 | 198 | 0.100 |
Why?
| | Inflammation | 2 | 2019 | 2465 | 0.100 |
Why?
| | Complement Pathway, Classical | 1 | 2011 | 18 | 0.100 |
Why?
| | Cell Differentiation | 2 | 2019 | 1696 | 0.090 |
Why?
| | Immunophenotyping | 1 | 2012 | 274 | 0.090 |
Why?
| | Cell Line | 3 | 2018 | 2629 | 0.090 |
Why?
| | Models, Immunological | 2 | 2010 | 90 | 0.090 |
Why?
| | Monocytes | 1 | 2013 | 503 | 0.090 |
Why?
| | Acute Disease | 1 | 2012 | 909 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2322 | 0.080 |
Why?
| | Proteins | 1 | 2015 | 906 | 0.080 |
Why?
| | Ovalbumin | 2 | 2009 | 161 | 0.080 |
Why?
| | Receptors, Complement | 1 | 2009 | 111 | 0.080 |
Why?
| | Cell Movement | 1 | 2013 | 863 | 0.080 |
Why?
| | Complement System Proteins | 1 | 2011 | 282 | 0.080 |
Why?
| | History, 20th Century | 1 | 2009 | 265 | 0.080 |
Why?
| | Cells, Cultured | 5 | 2015 | 3862 | 0.070 |
Why?
| | Phosphorylation | 3 | 2020 | 1559 | 0.070 |
Why?
| | Immunization, Secondary | 2 | 2004 | 82 | 0.070 |
Why?
| | Trinitrobenzenes | 1 | 2005 | 13 | 0.060 |
Why?
| | Mice, Congenic | 1 | 2005 | 21 | 0.060 |
Why?
| | Haptens | 1 | 2005 | 21 | 0.060 |
Why?
| | Antigen-Antibody Complex | 1 | 2005 | 84 | 0.060 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 347 | 0.060 |
Why?
| | Lymphocyte Depletion | 2 | 2016 | 115 | 0.060 |
Why?
| | Phosphoproteins | 2 | 2020 | 293 | 0.060 |
Why?
| | Hypersensitivity, Delayed | 1 | 2004 | 27 | 0.060 |
Why?
| | Mice, Inbred CBA | 1 | 2004 | 49 | 0.060 |
Why?
| | Female | 7 | 2020 | 59349 | 0.060 |
Why?
| | Inositol Polyphosphate 5-Phosphatases | 2 | 2015 | 4 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 787 | 0.050 |
Why?
| | Polymerase Chain Reaction | 2 | 2011 | 990 | 0.050 |
Why?
| | Male | 5 | 2019 | 55420 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 92 | 0.050 |
Why?
| | Immunoglobulin Light Chains | 1 | 2022 | 36 | 0.050 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2022 | 72 | 0.050 |
Why?
| | Thymus Gland | 1 | 2023 | 296 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2018 | 1075 | 0.050 |
Why?
| | Receptors, Virus | 1 | 2021 | 75 | 0.050 |
Why?
| | Immunization | 2 | 2014 | 397 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 92 | 0.040 |
Why?
| | Catfishes | 1 | 1999 | 8 | 0.040 |
Why?
| | Phenotype | 2 | 2019 | 2784 | 0.040 |
Why?
| | Culture Techniques | 1 | 1999 | 78 | 0.040 |
Why?
| | Tertiary Lymphoid Structures | 1 | 2019 | 6 | 0.040 |
Why?
| | Chemokine CXCL13 | 1 | 2019 | 7 | 0.040 |
Why?
| | Lymphopenia | 1 | 2019 | 49 | 0.040 |
Why?
| | Protein Structure, Quaternary | 1 | 1999 | 115 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2019 | 42 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 1999 | 200 | 0.040 |
Why?
| | Granuloma | 1 | 2019 | 82 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 315 | 0.040 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2019 | 90 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 1999 | 499 | 0.040 |
Why?
| | Chemokines | 1 | 2019 | 215 | 0.040 |
Why?
| | Beryllium | 1 | 2019 | 146 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2019 | 154 | 0.040 |
Why?
| | Lymphocytes | 1 | 2019 | 327 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 1999 | 341 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 2699 | 0.030 |
Why?
| | B-Cell Activating Factor | 1 | 2015 | 18 | 0.030 |
Why?
| | Rituximab | 1 | 2016 | 148 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 182 | 0.030 |
Why?
| | Immunoglobulin D | 1 | 2015 | 27 | 0.030 |
Why?
| | Cytidine Deaminase | 1 | 2015 | 57 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 198 | 0.030 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2014 | 5 | 0.030 |
Why?
| | Sialic Acid Binding Ig-like Lectin 2 | 1 | 2014 | 11 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 337 | 0.030 |
Why?
| | Lectins | 1 | 2014 | 42 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2014 | 174 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 397 | 0.030 |
Why?
| | Vaccination | 1 | 2021 | 1202 | 0.030 |
Why?
| | Fibroblasts | 1 | 2018 | 836 | 0.030 |
Why?
| | Precision Medicine | 1 | 2016 | 335 | 0.030 |
Why?
| | Insulin | 1 | 2022 | 2080 | 0.030 |
Why?
| | Dendritic Cells, Follicular | 1 | 2012 | 5 | 0.030 |
Why?
| | Receptors, Cell Surface | 1 | 2014 | 350 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 924 | 0.020 |
Why?
| | RNA | 1 | 2018 | 806 | 0.020 |
Why?
| | Chromatography, Agarose | 1 | 2011 | 4 | 0.020 |
Why?
| | Serum Amyloid P-Component | 1 | 2011 | 3 | 0.020 |
Why?
| | Enzyme-Linked Immunospot Assay | 1 | 2011 | 34 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1143 | 0.020 |
Why?
| | Gene Targeting | 1 | 2011 | 75 | 0.020 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2014 | 393 | 0.020 |
Why?
| | Tyrosine | 1 | 2011 | 210 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 304 | 0.020 |
Why?
| | DNA Primers | 1 | 2011 | 508 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2013 | 295 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2011 | 294 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2011 | 362 | 0.020 |
Why?
| | Gene Expression | 1 | 2014 | 1417 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2011 | 344 | 0.020 |
Why?
| | Lung | 1 | 2019 | 3521 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2006 | 68 | 0.020 |
Why?
| | Liver | 1 | 2013 | 1633 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1311 | 0.010 |
Why?
| | Hemolytic Plaque Technique | 1 | 2001 | 29 | 0.010 |
Why?
| | Immunization, Passive | 1 | 2001 | 73 | 0.010 |
Why?
| | Feedback | 1 | 2001 | 144 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1003 | 0.010 |
Why?
| | Kinetics | 1 | 2001 | 1547 | 0.010 |
Why?
|
|
Getahun's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|